NuMat Medtech awarded a grant by EIT Health Headstart Program to support the pre-clinical development of NuMat coating technologies

Palma, 29th of July 2019. The company NuMat Medtech was one of the 15 Spanish start-ups selected for 2019 Headstart support from EIT Health, which includes funding, mentoring and networking opportunities. NuMat has received a €40,000 grant that will allow to carry out pre-clincal safety studies of coating NM_973 based on the use of flavonoids.

NuMat has received financial support from EIT Health to carry out part of the pre-clinical studies under safety regulatory requirements by ISO 101993 – Biological evaluation of medical devices. Moreover, the grant will allow to NuMat to attend to several EIT Health events during the following year to connect with industrial players, public authorities and investors.

EIT Health is a network of best-in-class health innovators backed by the EU. In Innovation Projects, workshops, and start-up programmes, the EIT Health foster collaboration and support innovators with funding, expertise, and access to the market, so that breakthrough ideas can be implemented rapidly.

We would like to thank EIT Health for awarding us this grant that will allow us to progress in our company product development.